Harte Hanks (HHS)
(Delayed Data from NSDQ)
$7.15 USD
+0.17 (2.44%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.10 -0.05 (-0.70%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HHS 7.15 +0.17(2.44%)
Will HHS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HHS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HHS
Zacks Industry Outlook Highlights Omnicom Group, National CineMedia and Harte Hanks
3 Advertising & Marketing Stocks to Watch Amid Industry Woes
HHS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Interpublic Group (IPG) Lags Q3 Earnings and Revenue Estimates
Stagwell (STGW) Q2 Earnings and Revenues Lag Estimates
Information Services Group (III) Tops Q2 Earnings and Revenue Estimates
Other News for HHS
Harte Hanks to Report First Quarter 2024 Financial Results on May 9, 2024
Harte-Hanks: Q4 Earnings Snapshot
HHS Stock Earnings: Harte-Hanks Beats EPS, Beats Revenue for Q4 2023
Harte Hanks, Inc. (HHS) Q4 2023 Earnings Call Transcript
GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own